|
|
|
Market Research Report
Global Markets for Heart Defect Closure Devices 2009
|
Global Markets for Heart Defect Closure Devices 2009 published by Millennium Research Group in November, 2008. This report price starts from US $ 4197.
Abstract
The global heart defect closure device market - comprising sales of heart
defect closure devices for atrial septal defects (ASDs), patent foramen ovales
(PFOs), patent ductus arteriosi (PDAs), and ventricular septal defects (VSDs)
in the US, Europe (France, Germany, Italy, and the UK), and Japan - was valued
just over $110 million in 2008.
Research Methodology
The following report uses a number of methodologies to gather and present data
and analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include:
- Government Sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Center for Health Statistics data
- Heart Defect Closure Device Companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal Databases and Reports:
- Previous reports on similar/related sources
- General Internet Searches, Medical Literature, and Newspaper/Magazine
Searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research.
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is, thus, either discarded or marked as high or low priority. It
is then organized appropriately as determined by the structure and sectioning
of the report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various heart defect closure device
market segments. These assumptions are then used to determine hypotheses using
both inductive and deductive approaches. On the quantitative front, these
hypotheses result in full historical and projected market data sets (market
sizes [units and US$] and market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary
research, industry and medical experts are identified. These experts are now
contacted by telephone and asked to participate in interviews on recent trends
and developments in the industry. Interviews are either conducted at the time
of the initial call or scheduled at the convenience of the expert. Interview
questions are tailored to the expertise of the particular interviewee,
although in most cases, the most important questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then either augmented, discarded, or adjusted, based on the
views and positions put forth. Attempts are made, whenever possible, to cross
- check the views of various experts against each other and reach positions of
consensus on issues and market numbers.
In addition, a sample of key physician opinion leaders is also surveyed over
the telephone. Physicians are asked to comment on various issues/trends
regarding PFO closure, both in their own practice and in the overall market.
The responses provided are then used to strengthen or augment the assumptions
and hypotheses developed during the primary research phase.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross - checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 GLOBAL HEART DEFECT CLOSURE DEVICE MARKET
- 1.1 Market Overview
- 1.2 Condition Overview
- 1.2.1 Atrial Septal Defect
- 1.2.2 Patent Foramen Ovale
- 1.2.3 Patent Ductus Arteriosus
- 1.2.4 Ventricular Septal Defect
- 1.3 Market Analysis
- 1.3.1 Major Events and Assumptions
- 1.3.2 Procedures
- 1.3.2.1 Atrial Septal Defect Closure Device Procedures
- 1.3.2.2 Patent Foramen Ovale Closure Device Procedures
- 1.3.2.3 Patent Ductus Arteriosus Closure Procedures
- 1.3.2.4 Ventricular Septal Defect Closure Device Procedures
- 1.3.3 Patent Foramen Ovale Randomized Control Trial Review
- 1.3.3.1 Trial Summaries for Cryptogenic Strokes and Transient Ischemic
Attack Indications
- 1.3.3.2 Trial Summaries for Migraine Indications
- Completed Trials for Migraine Indications
- Ongoing Trials for Migraine Indications
- 1.3.4 Physician Feedback Regarding Patent Foramen Ovale Closure
- 1.3.5 Market Forecast
- 1.3.5.1 Atrial Septal Defect Closure Device Market
- 1.3.5.2 Patent Foramen Ovale Closure Device Market
- 1.3.5.3 Patent Ductus Arteriosus Closure Device Market
- 1.3.5.4 Ventricular Septal Defect Closure Device Market
- 1.3.6 Market Drivers and Limiters
- 1.3.6.1 Market Drivers
- 1.3.6.2 Market Limiters
- 1.4 Competitive Analysis
- 1.4.1 Competitive Landscape
- 1.4.2 Emerging Competitors
2.0 US HEART DEFECT CLOSURE DEVICE MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Major Events and Assumptions
- 2.2.2 Procedures
- 2.2.2.1 Atrial Septal Defect Closure Device Procedures
- 2.2.2.2 Patent Foramen Ovale Closure Device Procedures
- Physician Feedback Regarding Patent Foramen Ovale Closure
- 2.2.2.3 Patent Ductus Arteriosus Closure Device Procedures
- 2.2.2.4 Ventricular Septal Defect Closure Device Procedures
- 2.2.3 Market Forecast
- 2.2.3.1 Atrial Septal Defect Closure Device Market
- 2.2.3.2 Patent Foramen Ovale Closure Device Market
- 2.2.3.3 Patent Ductus Arteriosus Closure Device Market
- 2.2.3.4 Ventricle Septal Defect Closure Device Market
- 2.2.4 Market Drivers and Limiters
- 2.3 Competitive Analysis
3.0 EUROPEAN HEART DEFECT CLOSURE DEVICE MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Major Events and Assumptions
- 3.2.2 Procedures
- 3.2.2.1 Atrial Septal Defect Closure Device Procedures
- 3.2.2.2 Patent Foramen Ovale Closure Device Procedures
- Physician Feedback Regarding Patent Foramen Ovale Closure
- 3.2.2.3 Patent Ductus Arteriosus Closure Device Procedures
- 3.2.2.4 Ventricular Septal Defect Closure Device Procedures
- 3.2.3 Market Forecast
- 3.2.3.1 Atrial Septal Defect Closure Device Market
- 3.2.3.2 Patent Foramen Ovale Closure Device Market
- 3.2.3.3 Patent Ductus Arteriosus Closure Device Market
- 3.2.3.4 Ventricle Septal Defect Closure Device Market
- 3.2.4 Market Drivers and Limiters
- 3.3 Competitive Analysis
4.0 JAPANESE HEART DEFECT CLOSURE DEVICE MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Major Events and Assumptions
- 4.2.2 Procedures
- 4.2.3 Market Forecast
- 4.2.4 Market Drivers and Limiters
- 4.3 Competitive Analysis
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL EXHIBITS
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: Heart Defect Closure Device Market, Global (US$), 2007 - 2013
- Exhibit 2: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013
- Exhibit 3: Heart Defect Closure Device Market, by Country, Europe, 2007 -
2013
- Exhibit 4: Heart Defect Closure Device Market, by Indication, Japan,
(US$), 2007 - 2013
- Exhibit 5: Leading Competitors in the Global Heart Defect Closure Device
Market,2008
METHODOLOGY
- Exhibit 6: Currency Exchange Rates, 2008
CHAPTER 1: GLOBAL HEART DEFECT CLOSURE DEVICE MARKET
- Exhibit 7: Heart Defect Closure Device Market, Global (US$), 2007 - 2013
- Exhibit 8: Transcatheter Heart Defect Closure Procedures, by Region,
Global, 2007 - 2013
- Exhibit 9: Transcatheter Heart Defect Closure Procedures, by Indication,
Global, 2007 - 2013
- Exhibit 10: Transcatheter Heart Defect Closure Procedures, by Indication
and Region, 2007 - 2013
- Exhibit 11: Transcatheter Heart Defect Closure Procedure Growth, by
Indication and Region, 2008 - 2013
- Exhibit 12: CLOSE Clinical Trial Summary, 2008
- Exhibit 13: CLOSURE I Clinical Trial Summary, 2008
- Exhibit 14: PC-Trial Summary, 2008
- Exhibit 15: REDUCE Clinical Trial Summary, 2008
- Exhibit 16: RESPECT Clinical Trial Summary, 2008
- Exhibit 17: MIST I Clinical Trial Summary, 2008
- Exhibit 18: PREMIUM Clinical Trial Summary, 2008
- Exhibit 19: PRIMA Clinical Trial Summary, 2008
- Exhibit 20: Heart Defect Closure Device Market, by Region, Global (US$),
2007 - 2013
- Exhibit 21: Heart Defect Closure Device Market, by Indication, Global
(US$), 2007 - 2013
- Exhibit 22: Heart Closure Device Market, by Indication and Region, Global
(US$), 2007 - 2013
- Exhibit 23: Heart Defect Closure Device Market Growth, by Indication and
Region, 2008 - 2013
- Exhibit 24: Drivers and Limiters of the Heart Defect Closure Device
Market, Global
- Exhibit 25: Key Facts in the Competitive Landscape of the Heart Defect
Closure Device Market, Country, 2008
- Exhibit 26: Leading Competitors in the Heart Defect Closure Device Market,
as a % of Total, Global, 2008
- Exhibit 27: Leading Competitors in the Heart Defect Closure Device Market,
by Segment, as a % of Total, Global, 2008
- Exhibit 28: Leading Competitors in the Heart Defect Closure Device Market,
by Region, as a % of Total, Global, 2008
CHAPTER 2: US HEART DEFECT CLOSURE DEVICE MARKET
- Exhibit 29: Heart Defect Closure Device Market, US (US$), 2007 - 2013
- Exhibit 30: Transcatheter Heart Defect Closure Procedures, by Indication,
US, 2007 - 2013 (Graphical Format)
- Exhibit 31: Transcatheter Heart Defect Closure Procedures, by Indication,
US, 2007 - 2013 (Tabular Format)
- Exhibit 32: PFO Closure Device Procedures, by Indication, US, 2007 - 2013
- Exhibit 33: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013
- Exhibit 34: PDA Closure Procedures, by Type, US, 2007 - 2013
- Exhibit 35: Heart Defect Closure Device Market, by Indication, US (US$),
2007 - 2013 (Graphical Format)
- Exhibit 36: Heart Defect Closure Device Market, by Indication, US (US$),
2007 - 2013 (Tabular Format)
- Exhibit 37: Heart Defect Closure Device Market Growth, by Indication, US,
2008 - 2013
- Exhibit 38: Heart Defect Closure Device Market, by Indication, as a % of
Total, US, 2007 - 2013
- Exhibit 39: ASD Closure Device Units, by Indication, US, 2007 - 2013
(Graphical Format)
- Exhibit 40: ASD Closure Device Units, by Indication, US, 2007 - 2013
(Tabular Format)
- Exhibit 41: Drivers of the Heart Defect Closure Device Market, US
- Exhibit 42: Limiters of the Heart Defect Closure Device Market, US
- Exhibit 43: Leading Competitors in the Heart Defect Closure Device Market,
as a % of Total, US, 2007
- Exhibit 44: Leading Competitors in the Heart Defect Closure Device Market,
by Indication, as a % of Total, US, 2007
CHAPTER 3: EUROPEAN HEART DEFECT CLOSURE DEVICE MARKET
- Exhibit 45: Heart Defect Closure Device Market, Europe (US$), 2007 - 2013
- Exhibit 46: Transcatheter Heart Defect Closure Procedures, by Country,
Europe, 2007 - 2013
- Exhibit 47: Transcatheter Heart Defect Closure Procedures, by Indication,
Europe, 2007 - 2013
- Exhibit 48: Transcatheter Heart Defect Closure Procedures, by Indication
and Country, Europe, 2007 - 2013
- Exhibit 49: Transcatheter Heart Defect Closure Procedures, by Indication
and Country, Europe, 2007 - 2013 (Continued)
- Exhibit 50: Transcatheter Heart Defect Closure Procedure Growth, by
Indication and Country, Europe, 2008 - 2013
- Exhibit 51: Transcatheter Heart Defect Closure Procedure Growth, by
Indication and Country, Europe, 2008 - 2013 (Continued)
- Exhibit 52: PDA Closure Procedures, by Type and Country, Europe, 2007 -
2013
- Exhibit 53: PDA Closure Procedure Growth, by Type and Country, Europe,
2008 - 2013
- Exhibit 54: PDA Closure Procedure, by Country and Type, as a % of total,
Europe, 2007 - 2013
- Exhibit 55: Heart Defect Closure Device Market, by Country, Europe (US$),
2007 - 2013 (Graphical Format)
- Exhibit 56: Heart Defect Closure Device Market, by Indication, Europe
(US$), 2007 - 2013 (Graphical Format)
- Exhibit 57: Heart Defect Closure Device Market, by Country, Europe (US$),
2007 - 2013 (Tabular Format)
- Exhibit 58: Heart Defect Closure Device Market, by Country, Europe (€
and £), 2007 - 2013
- Exhibit 59: Heart Defect Closure Device Market Growth, by Country, Europe,
2008 - 2013
- Exhibit 60: Heart Defect Closure Device Market, by Indication, Europe
(US$), 2007 - 2013 (Tabular Format)
- Exhibit 61: Heart Defect Closure Device Market, by Indication, Europe
(€ and £), 2007 - 2013
- Exhibit 62: Heart Defect Closure Device Market Growth, by Indication,
Europe, 2008 - 2013
- Exhibit 63: ASD Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Graphical Format)
- Exhibit 64: ASD Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Tabular Format)
- Exhibit 65: ASD Closure Device Market, by Country, Europe, (€ and
£), 2007 - 2013
- Exhibit 66: ASD Closure Device Market Growth, by Country, Europe, 2008 -
2013
- Exhibit 67: PFO Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Graphical Format)
- Exhibit 68: PFO Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Tabular Format)
- Exhibit 69: PFO Closure Device Market, by Country, Europe (€ and
£), 2007 - 2013
- Exhibit 70: PFO Closure Device Market Growth, by Country, Europe, 2008 -
2013
- Exhibit 71: PDA Closure Device Market, by Country, Europe, (US$), 2007 -
2013 (Graphical Format)
- Exhibit 72: PDA Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Tabular Format)
- Exhibit 73: PDA Closure Device Market, by Country, Europe (€ and
£), 2007 - 2013
- Exhibit 74: PDA Closure Device Market Growth, by Country, Europe, 2008 -
2013
- Exhibit 75: VSD Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Graphical Format)
- Exhibit 76: VSD Closure Device Market, by Country, Europe (US$), 2007 -
2013 (Tabular Format)
- Exhibit 77: VSD Closure Device Market, by Country, Europe, (€ and
£), 2007 - 2013
- Exhibit 78: VSD Closure Device Market Growth, by Country, Europe, 2008 -
2013
- Exhibit 79: Drivers of the Heart Defect Closure Device Market, Europe
- Exhibit 80: Limiters of the Heart Defect Closure Device Market, Europe
- Exhibit 81: Leading Competitors in the Heart Defect Closure Device Market,
as a % of Total, Europe, 2008
- Exhibit 82: Leading Competitors in the Heart Defect Closure Device Market,
by Country, as a % of Total, Europe, 2008
- Exhibit 83: Leading Competitors in the Heart Defect Closure Device Market,
by Indication, as a % of Total, Europe, 2007
CHAPTER 4: JAPANESE HEART DEFECT CLOSURE DEVICE MARKET
- Exhibit 84: Heart Defect Closure Device Market, Japan (US$), 2007 - 2013
- Exhibit 85: Transcatheter Heart Defect Closure Procedures, by Indication,
Japan, 2007 - 2013 (Graphical Format)
- Exhibit 86: Transcatheter Heart Defect Closure Procedures, by Indication,
Japan, 2007 - 2013 (Graphical Format)
- Exhibit 87: PDA Closure Procedures, by Type, Japan, 2007 - 2013
- Exhibit 88: Heart Defect Closure Device Market, by Indication, Japan
(US$), 2007 - 2013 (Graphical Format)
- Exhibit 89: Heart Defect Closure Device Market, by Indication, Japan
(US$), 2007 - 2013 (Tabular Format)
- Exhibit 90: Heart Defect Closure Device Market, by Indication, Japan (¥),
2007 - 2013
- Exhibit 91: Heart Defect Closure Device Market Growth, by Indication,
Japan, 2008 - 2013
- Exhibit 92: Heart Defect Closure Device Market, by Indication, as a % of
Total, Japan, 2007 - 2013
- Exhibit 93: Drivers of the Heart Defect Closure Device Market, Japan
- Exhibit 94: Limiters of the Heart Defect Closure Device Market, Japan
APPENDIX B: SUPPLEMENTAL EXHIBITS
- Exhibit 95: Heart Defect Closure Device Market, Global (US$), 2007 - 2013
(Detailed Format)
- Exhibit 96: PFO Closure Device Procedures, by Device Type, US, 2007 - 2013
(Detailed Format)
- Exhibit 97: Heart Defect Closure Device Market, by Country, Europe, 2007 -
2013 (Detailed Format)
- Exhibit 98: Heart Defect Closure Device Market, by Indication, Japan,
(US$), 2007 - 2013 (Detailed Format)
|

|